Vanderbilt Clinical Trials

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

Purpose

The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)

Condition

cGVHD

Eligibility

Eligible Ages: Over 18 Years
Eligible Genders: All
Accepts Healthy Volunteers: No

Inclusion Criteria

Age ≥ 18 years inclusive at the time of signing the ICF - Allogeneic SCT 90 to 180 days prior to enrollment - Able to comprehend and willing to provide informed consent - Willing and able to complete participant-assessment questionnaires either alone or with minimal assistance from a caregiver and/or trained site personnel

Exclusion Criteria

There are no exclusion criteria for this study

Study Design

Phase
Study Type: Observational
Observational Model: Cohort
Time Perspective: Prospective

Arm Groups

Arm	Description	Assigned Intervention
At risk for GVHD	Equal or Greater than 18 years old post alloSCT	Other: Non-Interventional This is an observational study

Recruiting Locations

Vanderbilt University Medical Center
Nashville, Tennessee 37212

More Details

Status: Recruiting
Sponsor: Incyte Corporation

Study Contact

Incyte Corporation Call Center (US)
1.855.463.3463
medinfo@incyte.com

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.